<DOC>
	<DOCNO>NCT02296892</DOCNO>
	<brief_summary>A prospective , double-blind , randomize , placebo active control , multi-center , parallel group study compare remimazolam placebo , additional open label arm midazolam , patient undergo bronchoscopy .</brief_summary>
	<brief_title>A Phase III Study Remimazolam Patients Undergoing Bronchoscopy</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>Patients schedule undergo diagnostic therapeutic fiberoptic bronchoscopy bronchoscopy suite ( e.g . lavage , biopsy , brushing , foreign body extraction ) Bronchoscopy outside bronchoscopy suite ( e.g . Intensive Care Unit ) SpO2 &lt; 90 % ambient air , patient chronic continuous O2 support mechanical ventilation Forced expiratory volume ( FEV1 ) &lt; 1L Tracheal stenosis Planned laser bronchoscopy , rigid scope bronchoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>